Supira Medical, Inc. is a portfolio company of Shifamed, LLC., a highly-specialized medical innovation hub focused on developing advanced solutions that get to market faster, reduce risk, increase impact, and forge a path toward a world where all people are able to lead longer, healthier lives.
Location: United States, California, Los Gatos
Employees: 1-10
Total raised: $190M
Investors 2
| Date | Name | Website |
| - | 415 Capita... | 415capital... |
| - | Techlink V... | techlinkve... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 28.03.2025 | Series E | $120M | - |
| 21.11.2023 | Series D | $40M | - |
| 28.02.2022 | Series C | $30M | - |
Mentions in press and media 11
| Date | Title | Description |
| 08.04.2026 | Supira Medical Announces FDA Approval for SUPPORT II Pivotal Trial, Advances in Cardiogenic Shock, and Appointment of D. Keith Grossman to Board of Directors | Milestones underscore clinical progress and strengthen commercial foundation LOS GATOS, Calif., April 8, 2026 /PRNewswire/ -- Supira Medical, Inc. (Supira), a clinical-stage company focused on transforming the percutaneous ventricular assis... |
| 28.03.2025 | Supira Medical: $120 Million (Series E) Raised For Transforming The Percutaneous Ventricular Assist Device Market | Supira Medical – a clinical-stage Shifamed portfolio company – announced the completion of an oversubscribed Series E financing round, raising $120 million to accelerate the company’s mission of transforming the percutaneous ventricular ass... |
| 27.03.2025 | Supira Medical's $120 Million Leap: A New Era for Heart Health | In the heart of Silicon Valley, a revolution is brewing. Supira Medical, a clinical-stage company based in Los Gatos, California, has just secured a whopping $120 million in an oversubscribed Series E financing round. This significant capit... |
| 26.03.2025 | Supira Medical raises $120M to develop catheter-based ventricular heart pump | Supira Medical has raised $120 million to complete the clinical development of its temporary heart pump, designed for patients undergoing high-risk cardiac procedures or suffering from shock. The Shifamed portfolio company’s percutaneous ve... |
| 26.03.2025 | Supira Medical Secures $120M Oversubscribed Series E Financing and Completes Enrollment of SUPPORT I Early Feasibility Study in the United States | LOS GATOS, Calif., March 26, 2025 /PRNewswire/ -- Supira Medical, Inc. (Supira), a clinical-stage Shifamed portfolio company, today announced the successful completion of an oversubscribed Series E financing round, raising $120M to accelera... |
| 26.03.2025 | Supira Medical Raises $120M in Series E Financing | Supira Medical, Inc., a Los Gatos, CA-based percutaneous ventricular assist device (pVAD) company, closed a $120M Series E financing round. The round was led by new investors Novo Holdings and Qatar Investment Authority (QIA), with particip... |
| 21.11.2023 | Supira Medical Closes $40M In Series D Financing | Supera Medical, a Los Gatos, CA-based company advancing a percutaneous ventricular assist device (pVAD), raised $40M in Series D funding. The round was led by Cormorant Asset Management and The Capital Partnership (TCP), with participation ... |
| 03.05.2023 | Magenta Medical Rakes In $55M for ‘World’s Smallest Heart Pump’ | Magenta Medical — an Israeli company developing what it bills as “the world’s smallest heart pump” — closed a $55 million financing round on Wednesday. The round was led by OrbiMed, with participation from New Enterprise Associates, Pitango... |
| 28.02.2022 | Supira Medical Closes $30M Series C Funding | Supira Medical, a Los Gatos, CA-based Shifamed portfolio company focused on developing a next-generation solution for temporary mechanical circulatory support, raised $30M in Series C funding. The round was led by Cormorant Asset Management... |
| 13.06.2018 | Supira Medical Raises $15.5M in Series A Financing | Supira Medical, a Campbell, Calif.-based developer of a percutaneous ventricular assist device (pVAD) for use in high-risk patients undergoing interventional procedures, raised $15.5M in funding. The round was led by The Capital Partnership... |
Show more